Skip to content
52
PricingSign in

Connections

Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc

21 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc

Federal lobbying records

Open page
Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc: all 10 bills it lobbied on and all 10 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc
HR 8467Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named HR 8467, “ZOMBIE Act”, in 5 lobbying reports.5 reports
S 832Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named S 832, “EPIC Act of 2025”, in 5 lobbying reports.5 reports
HR 1492Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named HR 1492, “To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program”, in 5 lobbying reports.5 reports
S 1666Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named S 1666, “Improving Social Security’s Service to Victims of Identity Theft Act”, in 3 lobbying reports.3 reports
HR 1842Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named HR 1842, “PAW Act of 2025”, in 3 lobbying reports.3 reports
HR 3419Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named HR 3419, “To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs”, in 3 lobbying reports.3 reports
S 339Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named S 339, “A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests”, in 2 lobbying reports.2 reports
HR 842Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named HR 842, “Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act”, in 2 lobbying reports.2 reports
S 1862Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named S 1862, “ORPHAN Cures Act”, in 2 lobbying reports.2 reports
HR 946Bills it lobbied onBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc named HR 946, “ORPHAN Cures Act”, in 2 lobbying reports.2 reports
Charles GrassleyLawmakers it funded or lobbiedCharles Grassley leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Claudia TenneyLawmakers it funded or lobbiedClaudia Tenney leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
David ValadaoLawmakers it funded or lobbiedDavid Valadao leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Gary PalmerLawmakers it funded or lobbiedGary Palmer leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Gregory MurphyLawmakers it funded or lobbiedGregory Murphy leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Jodey ArringtonLawmakers it funded or lobbiedJodey Arrington leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
John BarrassoLawmakers it funded or lobbiedJohn Barrasso leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
John JoyceLawmakers it funded or lobbiedJohn Joyce leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Michael CrapoLawmakers it funded or lobbiedMichael Crapo leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Thom TillisLawmakers it funded or lobbiedThom Tillis leads 1 bill Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc lobbied on.Leads 1 of these bills
Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, IncSource recordsBoehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc has an explicit source reference to Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, Inc.None

In the news

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…